BioSpace News Archive

Drug Development

Concordia Healthcare Corp Announces First Patients Enrolled In Phase 2 Clinical Trial Using Photodynamic Therapy With PHOTOFRIN(R) For Patients With Mesothelioma

August 11, 2014
·
7 min read
Drug Development

Catalyst Pharmaceutical Partners, Inc. Provides Updates On Progress Of Phase 3 Firdapse Study In Patients With Lambert-Eaton Myasthenic Syndrome (LEMS)

August 11, 2014
·
6 min read
Drug Development

Genmab A/S Announces New Phase 3 Study Of Daratumumab In Front Line Multiple Myeloma

August 11, 2014
·
4 min read
BioMidwest

Cellectar Biosciences Files Investigational New Drug Application To Evaluate I-131-CLR1404 In Clinical Trials In Relapsed Or Refractory Multiple Myeloma

August 11, 2014
·
4 min read
Genetown

InspireMD Ltd. To Announce Results Of CGuard™ CARENET Trial At The TCT Innovation Session On Late Breaking Early Human Clinical Studies

August 11, 2014
·
5 min read
Business

Amarantus BioSciences, Inc. Enters Into Research Collaboration With The Buck Institute for Age Research For MANF

August 11, 2014
·
10 min read
Drug Development

Mirati Therapeutics Receives Orphan Designation From U.S. FDA For Mocetinostat In Diffuse Large B-Cell Lymphoma

August 11, 2014
·
4 min read
Business

Repligen Corporation Reports Second Quarter 2014 Financial Results

August 11, 2014
·
13 min read
Business

Alcobra Announces Second Quarter Financial Results And Provides Corporate Update

August 11, 2014
·
8 min read
Drug Development

Northwest Biotherapeutics Provides Update About Phase 3 Dcvax®-L Trial For Gbm And “Information Arm” Compassionate Use Patients

August 11, 2014
·
5 min read